Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
about
Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart StudyMyocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cellsRegulation of the MEF2 family of transcription factors by p38Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular systemSmad proteins function as co-modulators for MEF2 transcriptional regulatory proteinsDifferential localization of HDAC4 orchestrates muscle differentiationPC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C.MEF2C DNA-binding activity is inhibited through its interaction with the regulatory protein Ki-1/57Skeletal myosin light chain kinase regulates skeletal myogenesis by phosphorylation of MEF2CThe MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10Cell-specific activation of the atrial natriuretic factor promoter by PITX2 and MEF2AThe Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesisskNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regenerationCalreticulin signals upstream of calcineurin and MEF2C in a critical Ca(2+)-dependent signaling cascadeMEF2-dependent recruitment of the HAND1 transcription factor results in synergistic activation of target promotersRE1-silencing transcription factor (REST) and REST-interacting LIM domain protein (RILP) affect P19CL6 differentiationControl of the SOST bone enhancer by PTH using MEF2 transcription factorsNuclear calcium/calmodulin-dependent protein kinase IIdelta preferentially transmits signals to histone deacetylase 4 in cardiac cellsMultiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defectsInteraction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiationJumonji represses atrial natriuretic factor gene expression by inhibiting transcriptional activities of cardiac transcription factorsHistone deacetylase signaling in cardioprotectionGATA-dependent recruitment of MEF2 proteins to target promotersHRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivoA long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNATbx20 regulates a genetic program essential to adult mouse cardiomyocyte functionTranscription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivomef2ca is required in cranial neural crest to effect Endothelin1 signaling in zebrafishThe transcription factor MEF2C is required for craniofacial developmentModulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activityKnockout of ERK5 causes multiple defects in placental and embryonic developmentMolecular and cellular mechanisms of cardiotoxicity.Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activityLong Non-coding RNAs in the CytoplasmMEF2 transcription factors: developmental regulators and emerging cancer genesTroponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease
P2860
Q21093317-44BD2DAB-65FE-400F-AFA7-351188CEB813Q22008552-5FD7A459-28AC-45F1-B638-B2D3DDF856D8Q22008562-6392C22F-49E3-434C-B7CC-E9A45DBC7D71Q22253240-FDB09051-E0B7-4A56-9BF8-9412DBC0DC0DQ24290752-39575F67-BBDE-4E48-9E45-CD5351283CDFQ24291565-5F7A3422-8BE3-46B2-849B-481311479BAEQ24297205-20C30E87-8925-4091-8840-EE0DB5EB82D8Q24301051-4AC90280-790E-4E0C-9B29-EABD7CBF2D4BQ24301871-9F627569-0A18-4F86-AF67-C1A9F3361130Q24304297-B54D5192-3CFE-4340-8E58-499F06152731Q24306186-A3C6E048-CF01-4116-8EAD-89E68BC09306Q24306223-3E209B88-6152-4CAF-85D8-BBEDAB024C8CQ24306754-9AEE9624-3D7F-48C3-AA82-07A1E1DF9249Q24306858-7B2E9C9C-AED0-4186-BDA5-47ACC9443071Q24309833-5C453867-A1D0-437D-B804-20CE533B94CCQ24322741-7D72BBE6-8416-49A2-A548-08AA97C72554Q24337339-478DB7A4-3C16-428C-A5E0-C6E59E66B284Q24337519-C97B3FE2-6184-4EF7-9FBD-FADD23DC0FAFQ24533544-4EDEDFF4-56A2-49D5-AE05-3AE507DCDC61Q24534817-DF387371-4CC0-41F3-8419-5623FEB1B2E4Q24548255-4EF7EB8D-E48D-446A-903A-180DCC6CD53DQ24554412-B93C5393-7E81-4533-A3E1-D13C46256806Q24554516-CED1DE12-1CB9-488E-B075-A5C0EC4AB31BQ24555638-3B667CC3-3C3E-4018-AF18-31FD9429E4BAQ24559996-AB9F713C-3775-4820-B394-C964B619B7DDQ24568237-B8DECA1F-24AC-4479-AAB7-1C7D53F25683Q24599616-5AD76117-7C4D-49B7-B8B3-2D46A4CAFAECQ24623607-DC743B78-6167-4D41-BEF3-B931DA8DB6B9Q24630341-6504B412-5241-4693-A09F-AF3845D001C2Q24634382-1207061B-E7BA-4B8C-A511-D1E335966C41Q24644531-512CB037-9E0F-4A25-AE5B-9F9BEA360DCCQ24670788-E35D9C2F-900F-48E8-BC9A-2202471E25F2Q24672010-134F8CA6-CFFA-457F-961E-C6D7806130A1Q24673391-5146D2DB-2688-4D1E-A78C-BFDB736D0DE8Q24791222-E22AE45B-1AED-4B32-A67E-9065060E76EBQ24814079-39D6ACB9-0FDB-4A1A-8C8B-CC25E057A169Q25256622-944730A4-0C6A-4215-ABF5-C5A799174D9BQ26750883-2CB974DF-33B3-40C5-9C91-DA0F86A89FCDQ26778515-348D6661-DD1E-4783-8BA9-37BA445E4B0EQ26864088-130FB5DA-1E60-40A0-95F6-CF32FD7ED706
P2860
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
description
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Science
@fr
artículu científicu espublizáu en 1997
@ast
im Mai 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/05/30)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/05/30)
@nl
наукова стаття, опублікована в травні 1997
@uk
name
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
@ast
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
@en
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
@nl
type
label
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
@ast
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
@en
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
@nl
prefLabel
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
@ast
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
@en
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
@nl
P2093
P2860
P3181
P1433
P1476
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
@en
P2093
P2860
P304
P3181
P356
10.1126/SCIENCE.276.5317.1404
P407
P577
1997-05-30T00:00:00Z